The six groups comprise extended-spectrum betalactamase producing Enterobacteriaceae (ESBL-E), carbapenem-resistant Enterobacteriaceae (CRE), methicillin-resistant (MRSA), vancomycin-resistant enterococci (VRE), and both ceftazidime and/or imipenem-resistant spp. the first estimation of ARB colonization rates in hospitalized patients residing in SWIO (2015C2017). Using BFLS ARB colonization rates in Reunion Island (France) as the reference for estimating odds ratio, we identified at risk patients based on their territory of residence. Results The survey pointed to significantly higher overall ARB colonization rates in patients from Comoros, Madagascar, Mayotte, and Seychelles compared to Reunion Island as the reference. Extended-spectrum betalactamase producing Enterobacteriaceae was found to be the most common ARB group colonizing patients from SWIO territories. The highest MRSA colonization rates were observed in patients from Mayotte and Seychelles. Colonization by carbapenem-resistant Enterobacteriaceae (CRE) was highest in patients from Mauritius. Conclusion These results identify high ARB colonization rates in hospitalized patients from SWIO territories that require further investigation, particularly CRE in Mauritius and MRSA in Seychelles and Mayotte. This study is the first step toward the implementation of a broader regional ARB surveillance system. (MRSA) [2]. The South-Western Indian Ocean (SWIO) region contains the islands of the Union of Comoros, Madagascar, Mauritius, Mayotte (France), Reunion Island (France), and Seychelles. Based on a review of the literature, ESBL-E and carbapenem-resistant Enterobacteriaceae (CRE) were identified as a main public and veterinary health issue for SWIO [3]. Antimicrobial resistance has been considered a public health priority in the region since 2015. However, the absence of an ARB surveillance network in most SWIO territories and rare publications on the topic prevented researchers from identifying the most affected islands and the implementation of targeted action plans. Felix-Guyon University hospital in Reunion Island is well suited for medical evacuations and receives most patients evacuated from other islands of SWIO. Since 2015, an ARB screening strategy has been in place for all those patients residing abroad who arrive via medical evacuation, or who frequented a foreign country in the three preceding months, and/or were hospitalized abroad in the past 12 months. All patients admitted to the intensive care patients in Felix-Guyon hospital are screened to avoid introducing ARB in the unit. Based on comprehensive hospital laboratory ARB screening data, we estimated the prevalence of colonization by ARB (i.e. ESBL-E, CRE, MRSA, vancomycin-resistant enterococci, and both ceftazidime and/or imipenem-resistant spp. (ACB), and ceftazidime and/or imipenem-resistant spp. (PSA)) of hospitalized patients residing in SWIO. This is the first estimation of the ARB colonization rates in patients from SWIO territories using standard indicators. Methods Data collection MS436 and inclusion criteria We conducted a retrospective survey of all patients admitted to the Felix-Guyon University hospital, which is the main hospital in Reunion Island, between 2015 and 2017. Only patients who resided in SWIO were included. All the patients were screened for ARB detection (i.e. anal for ESBL-E, CRE, VRE, ACB, PSA, and nasal swabbing for MRSA). For Reunion Island, only patients admitted to the intensive care unit (all patients were screened) were used as the reference to estimate odds ratio. MS436 Definition of ARB Bacterial species were routinely identified for all those isolates using MALDI-TOF mass spectrometry (Bruker Daltonics, Bremen, Germany). Antimicrobial susceptibility testing was performed MS436 using the disc diffusion method according to guidelines published by the Committee on Antimicrobial Susceptibility Testing of the French Society of Microbiology in 2015 [4]. The ARB groups included in the survey were: (i) resistant to oxacillin was designated as methicillin-resistant (MRSA) according to the French national multidrug-resistant bacteria surveillance network [5];(ii) Enterobacteriaceae resistant to cefotaxime and/or ceftazidime and/or cefepime were designated as ESBL-E if a synergy between third-generation cephalosporins and clavulanic acid was confirmed by the disc diffusion method according to French recommendations [4]. ESBL-E definition was according to the French national multidrug-resistant bacteria surveillance network [5];(iii) Enterobacteriaceae resistant to imipenem and/or ertapenem were confirmed for the presence of relevant resistance genes by PCR (X-pert Carba-R, GeneXpert, Cepheid, Sunnyvale, USA) and designated as carbapenem-resistant Enterobacteriaceae (CRE).(iv) resistant to vancomycin and/or teicoplanin and confirmed for the presence of relevant resistance genes by PCR (X-pert vanA/vanB, GeneXpert, Cepheid, Sunnyvale, USA) were designated by vancomycin-resistant enterococci (VRE);(v) both spp. (ACB) and (vi) spp. (PSA) included in our survey were ceftazidime and/or imipenem resistant. A patient was considered ARB positive if one or more ARB group was isolated from that patient. Statistical analyses ARB colonization rates in patients were compared based on their territory of residence using a logistic regression analysis with ARB colonization as the dependent variable and the patients territory of MS436 residence as the explanatory variable. Odds ratio were calculated using.